STIMNeuronetics, Inc.

Nasdaq neurostar.com


$ 1.77 $ 0.03 (1.71 %)    

Wednesday, 03-Jul-2024 12:24:25 EDT
QQQ $ 490.95 $ 4.06 (0.83 %)
DIA $ 392.84 $ -0.46 (-0.12 %)
SPY $ 551.46 $ 2.45 (0.45 %)
TLT $ 91.86 $ 1.19 (1.31 %)
GLD $ 217.99 $ 2.43 (1.13 %)
$ 1.78
$ 1.79
$ 1.77 x 100
$ 1.79 x 200
$ 1.77 - $ 1.79
$ 1.03 - $ 5.07
19,616
na
52.46M
$ 1.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-07-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-15-2023 03-31-2023 10-Q
6 03-07-2023 12-31-2022 10-K
7 11-08-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-12-2022 03-31-2022 10-Q
10 03-08-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 03-02-2021 12-31-2020 10-K
15 11-02-2020 09-30-2020 10-Q
16 08-04-2020 06-30-2020 10-Q
17 05-05-2020 03-31-2020 10-Q
18 03-03-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-07-2019 03-31-2019 10-Q
22 03-05-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 william-blair-upgrades-neuronetics-to-outperform

William Blair analyst Margaret Kaczor upgrades Neuronetics (NASDAQ:STIM) from Market Perform to Outperform.

 neuronetics-q1-eps-027-beats-034-estimate-sales-1742m-beat-1712m-estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.31) b...

 neuronetics-inc-announces-new-publication-in-brain-stimulation-confirms-full-tms-treatment-course-is-vital

Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that imp...

 top-5-health-care-stocks-that-may-plunge-in-march

As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as...

 why-landos-biopharma-shares-are-trading-higher-by-over-170-here-are-other-stocks-moving-in-mondays-mid-day-session

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.

 neuronetics-q4-gaap-eps-019-beats-026-estimate-sales-2031m-beat-1985m-estimate

Neuronetics (NASDAQ:STIM) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.26) b...

 earnings-scheduled-for-march-5-2024

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2...

 earnings-outlook-for-neuronetics
Earnings Outlook For Neuronetics
03/04/2024 18:02:28

 neuronetics-reports-fy23-preliminary-unaudited-total-revenue-is-expected-to-be-over-71m-as-compared-to-previously-stated-guidance-of-70m-72m

Full Year 2023Preliminary unaudited total revenue is expected to be over $71 million as compared to previously stated guidance ...